XML 47 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2018
Fair Value Disclosures [Abstract]  
Fair Value Measurements on a Recurring Basis
The following table provides information by level for assets and liabilities that are measured at fair value on a recurring basis (in thousands):
 
 
Fair Value as of June 30, 2018
 
Fair Value Measurements Using Inputs Considered as:
 
 
 
Level 1
 
Level 2
 
Level 3
Liabilities:
 
 
 
 
 
 
 
 
Derivative liabilities - designated as cash flow hedges (foreign currency exchange rate "FX")
 
$
1,209

 
$

 
$
1,209

 
$

Derivative liabilities - designated as cash flow hedges (interest rate swaps)
 
1,221

 

 
1,221

 

Derivative liabilities - freestanding instruments (FX)
 
827

 

 
827

 

Contingent consideration (1)
 
181,133

 

 

 
181,133

 
 
$
184,390

 
$

 
$
3,257

 
$
181,133

 
 
Fair Value as of December 31, 2017
 
Fair Value Measurements Using Inputs Considered as:
 
 
 
Level 1
 
Level 2
 
Level 3
Assets:
 
 
 
 
 
 
 
 
Derivative assets - freestanding instruments (FX)
 
$
519

 
$

 
$
519

 
$

 
 
$
519

 
$

 
$
519

 
$

 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
Derivative liabilities - designated as cash flow hedges (FX)
 
$
460

 
$

 
$
460

 
$

Derivative liabilities - designated as cash flow hedges (interest rate swaps)
 
1,585

 

 
1,585

 

Contingent consideration (1)
 
33,973

 

 

 
33,973

 
 
$
36,018

 
$

 
$
2,045

 
$
33,973


(1)
The contingent consideration liability represents contingent payments related to five completed acquisitions: Cellplex PTY Ltd., Inversiones Drilltex SAS, Caisson, ImThera and TandemLife.
Reconciliation of Beginning and Ending Balances of Contingent Consideration
The following table provides a reconciliation of the beginning and ending balance of the contingent consideration liability (in thousands):
Total contingent consideration liability at December 31, 2017
 
$
33,973

Purchase price - ImThera contingent consideration
 
112,744

Purchase price - TandemLife contingent consideration
 
40,190

Payments
 
(196
)
Changes in fair value (1)
 
(5,546
)
Effect of changes in foreign currency exchange rates
 
(32
)
Total contingent consideration liability at June 30, 2018
 
181,133

Less current portion of contingent consideration liability at June 30, 2018
 
2,684

Long-term portion of contingent consideration liability at June 30, 2018
 
$
178,449

(1)
Includes a decrease of $6.1 million due to the delay in the timing of anticipated regulatory approval for ImThera. See “Note 3. Business Combinations” for additional discussion.